Study to Evaluate Safety & Efficacy of NaBen® as Add-on Treatment for Schizophrenia in Adults
Clinical trial NCT02261519 · TERMINATED
Trial details
- NCT number
- NCT02261519
- Sponsor
- SyneuRx International (Taiwan) Corp
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-29
- Primary completion
- 2023-11-29
- Enrollment
- 280
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.